Incyte Corp. diskutieren
Incyte Corp.
WKN: 896133 / Symbol: INCY / Name: Incyte / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
61,62 €
0,16 %
Gewinnmitnahmen
Der Wert hat geflogen und soll in den kommenden Tagen bläst
(Zielkurs erreicht)
Sell Incyte Corp.
Sell Incyte Corp.
Buy Incyte Corp.
Sell Incyte Corp.
Buy Incyte Corp.
Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at JMP Securities. They now have a $113.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $74.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $92.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $91.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $91.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $86.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $78.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Truist Financial Co. from $91.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Citigroup Inc. from $82.00 to $81.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $81.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $92.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for INCY provided by MarketBeat
Neueste Beiträge
Deutsche_Bank_Aktien in Man Group plc diskutieren